August 31, 2021 in References Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better PJWCreative 0 Like Post Comments Off on Surface Ligand Valency and Immunoliposome Binding: when More Is Not Always Better Read More
September 28, 2019 in References Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs PJWCreative 0 Like Post 0 Comment Read More
October 26, 2018 in References Safety and pharmacokinetics of MM-302, a HER2-targeted antibody–liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study PJWCreative 0 Like Post 0 Comment Read More
September 5, 2008 in References Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification PJWCreative 0 Like Post 0 Comment Read More
September 5, 2008 in Publications Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification PJWCreative 0 Like Post Comments Off on Preclinical Manufacture of an Anti-HER2 scFv-PEG-DSPE, Liposome-Inserting Conjugate. 1. Gram-Scale Production and Purification Read More
July 3, 2006 in References Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models PJWCreative 0 Like Post 0 Comment Read More
English 
简体中文